31 related articles for article (PubMed ID: 38440951)
1. Recommendations for Use of p16/Ki67 Dual Stain for Management of Individuals Testing Positive for Human Papillomavirus.
Clarke MA; Wentzensen N; Perkins RB; Garcia F; Arrindell D; Chelmow D; Cheung LC; Darragh TM; Egemen D; Guido R; Huh W; Locke A; Lorey TS; Nayar R; Risley C; Saslow D; Smith RA; Unger ER; Massad LS;
J Low Genit Tract Dis; 2024 Apr; 28(2):124-130. PubMed ID: 38446575
[TBL] [Abstract][Full Text] [Related]
2. Eurogin roadmap 2017: Triage strategies for the management of HPV-positive women in cervical screening programs.
Cuschieri K; Ronco G; Lorincz A; Smith L; Ogilvie G; Mirabello L; Carozzi F; Cubie H; Wentzensen N; Snijders P; Arbyn M; Monsonego J; Franceschi S
Int J Cancer; 2018 Aug; 143(4):735-745. PubMed ID: 29341110
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of dual p16/Ki-67 immunostaining on anal cytology specimens.
Smithgall MC; Towne WS; Gonzalez AA; Cimic A
Diagn Cytopathol; 2024 Apr; ():. PubMed ID: 38666389
[TBL] [Abstract][Full Text] [Related]
4. A Prospective Study on the Progression, Recurrence, and Regression of Cervical Lesions: Assessing Various Screening Approaches.
Gisca T; Munteanu IV; Vasilache IA; Melinte-Popescu AS; Volovat S; Scripcariu IS; Balan RA; Pavaleanu I; Socolov R; Carauleanu A; Vaduva C; Melinte-Popescu M; Adam AM; Adam G; Vicoveanu P; Socolov D
J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592206
[TBL] [Abstract][Full Text] [Related]
5. The road ahead for cervical cancer prevention and control.
Tota JE; Ramana-Kumar AV; El-Khatib Z; Franco EL
Curr Oncol; 2014 Apr; 21(2):e255-64. PubMed ID: 24764711
[TBL] [Abstract][Full Text] [Related]
6. Triage of HPV positive women in cervical cancer screening.
Wentzensen N; Schiffman M; Palmer T; Arbyn M
J Clin Virol; 2016 Mar; 76 Suppl 1(Suppl 1):S49-S55. PubMed ID: 26643050
[TBL] [Abstract][Full Text] [Related]
7. Triage Strategies for Non-16/Non-18 HPV-Positive Women in Primary HPV-Based Cervical Cancer Screening: p16/Ki67 Dual Stain vs. Cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894462
[TBL] [Abstract][Full Text] [Related]
8. [Clinical value of p16
Song FB; Du H; Xiao AM; Wang C; Huang X; Yan PS; Liu ZH; Qu XF; Belinson JEROMEL; Wu RF
Zhonghua Fu Chan Ke Za Zhi; 2020 Nov; 55(11):784-790. PubMed ID: 33228350
[No Abstract] [Full Text] [Related]
9. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
Trzeszcz M; Mazurec M; Jach R; Mazurec K; Kotkowska-Szeps I; Kania M; Wantuchowicz M; Wasowska J; Duczek-Polakiewicz M; Rozmus P; Streb J; Halon A
J Med Virol; 2023 Nov; 95(11):e29271. PubMed ID: 38009626
[TBL] [Abstract][Full Text] [Related]
10. Comparison of HPV-16 and HPV-18 Genotyping and Cytological Testing as Triage Testing Within Human Papillomavirus-Based Screening in Mexico.
Torres-Ibarra L; Cuzick J; Lorincz AT; Spiegelman D; Lazcano-Ponce E; Franco EL; Moscicki AB; Mahmud SM; Wheeler CM; Rivera-Paredez B; Hernández-López R; León-Maldonado L; Salmerón J;
JAMA Netw Open; 2019 Nov; 2(11):e1915781. PubMed ID: 31747033
[TBL] [Abstract][Full Text] [Related]
11. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
Wright TC; Behrens CM; Ranger-Moore J; Rehm S; Sharma A; Stoler MH; Ridder R
Gynecol Oncol; 2017 Jan; 144(1):51-56. PubMed ID: 28094038
[TBL] [Abstract][Full Text] [Related]
12. Should we use risk selection tests for HPV 16 and/or 18 positive cases: Comparison of p16/Ki67 and cytology.
Mazurec K; Trzeszcz M; Mazurec M; Streb J; Halon A; Jach R
J Med Virol; 2024 Mar; 96(3):e29500. PubMed ID: 38440951
[TBL] [Abstract][Full Text] [Related]
13. Management of high-risk HPV-positive women for detection of cervical (pre)cancer.
Luttmer R; De Strooper LM; Steenbergen RD; Berkhof J; Snijders PJ; Heideman DA; Meijer CJ
Expert Rev Mol Diagn; 2016 Sep; 16(9):961-74. PubMed ID: 27459506
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
